Trial Profile
Effect of tolvaptan versus carperitide in patients with acute decompensated heart failure, reduced left ventricular systolic function and low blood pressure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Carperitide
- Indications Decompensated heart failure
- Focus Therapeutic Use
- 15 Apr 2015 New trial record